Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Modern Approach to Dyslipidemia
Amanda J. Berberich, Robert A. Hegele
Endocrine Reviews (2021) Vol. 43, Iss. 4, pp. 611-653
Open Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
Tamara Glavinovic, George Thanassoulis, Jacqueline de Graaf, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 20
Open Access | Times Cited: 80
DNA methylation levels may contribute to severe hypertriglyceridemia in multifactorial chylomicronemia syndrome
Simon‐Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Clinical Biochemistry (2025) Vol. 135, pp. 110873-110873
Closed Access | Times Cited: 3
Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis
Qian Zhang, Yi Zhao, Long Fei Li, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1207-1233
Open Access | Times Cited: 2
Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
Anna Martin, Sonja Lang, Tobias Goeser, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 533-546
Open Access | Times Cited: 49
Biological and bioactive components of bitter leaf (Vernonia amygdalina leaf): Insight on health and nutritional benefits. A review
Great Iruoghene Edo, Princess Oghenekeno Samuel, Agatha Ngukuran Jikah, et al.
Food Chemistry Advances (2023) Vol. 3, pp. 100488-100488
Open Access | Times Cited: 33
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease
Om P Ganda
Current Opinion in Lipidology (2023) Vol. 34, Iss. 3, pp. 105-113
Closed Access | Times Cited: 28
Polymorphic short tandem repeats make widespread contributions to blood and serum traits
Jonathan Margoliash, Shai Fuchs, Yang Li, et al.
Cell Genomics (2023) Vol. 3, Iss. 12, pp. 100458-100458
Open Access | Times Cited: 26
LOX-1 in Cardiovascular Disease: A Comprehensive Molecular and Clinical Review
Maria Sánchez‐León, Karen Julissa Loaeza-Reyes, Carlos Alberto Matias‐Cervantes, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5276-5276
Open Access | Times Cited: 15
From Atherosclerotic Plaque to Myocardial Infarction—The Leading Cause of Coronary Artery Occlusion
Ewelina Młynarska, Witold Czarnik, Piotr Fularski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7295-7295
Open Access | Times Cited: 13
Novel RNA-Based Therapies in the Management of Dyslipidemias
Constantine E. Kosmas, Maria D. Bousvarou, Donatos Tsamoulis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1026-1026
Open Access | Times Cited: 1
Cross-sectional and Longitudinal Associations Between Family History of Type 2 Diabetes Mellitus, Hypertension, and Dyslipidemia and Their Prevalence and Incidence
Izumi Ikeda, Risa Igarashi, Kazuya Fujihara, et al.
Mayo Clinic Proceedings (2025)
Open Access | Times Cited: 1
Exploring the Therapeutic Potential of Artemisia and Salvia Genera in Cancer, Diabetes, and Cardiovascular Diseases: A Short Review of Clinical Evidence
Wilson R. Tavares, Ana M. L. Seca, Maria do Carmo Barreto
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 1028-1028
Open Access | Times Cited: 1
Dietary management of dyslipidemia and the impact of dietary patterns on lipid disorders
Anandita Agarwala, Kristina Petersen, Fatemeh Jafari, et al.
Progress in Cardiovascular Diseases (2022) Vol. 75, pp. 49-58
Closed Access | Times Cited: 30
Safety and efficacy of therapies for chylomicronemia
Isabel Shamsudeen, Robert A. Hegele
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 4, pp. 395-405
Open Access | Times Cited: 29
Advances in Treatment of Dyslipidemia
Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13288-13288
Open Access | Times Cited: 20
Effects of Vegetal Extracts and Metabolites against Oxidative Stress and Associated Diseases: Studies in Caenorhabditis elegans
Estefani Yaquelin Hernández‐Cruz, Dianelena Eugenio-Pérez, Karla Jaqueline Ramírez-Magaña, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 8936-8959
Open Access | Times Cited: 19
The Importance of Metabolic and Environmental Factors in the Occurrence of Oxidative Stress during Pregnancy
Miljana Z. Jovandarić, Sandra Babić, Misela Raus, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11964-11964
Open Access | Times Cited: 17
Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)
Constantine E. Kosmas, Maria D. Bousvarou, E Papakonstantinou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13622-13622
Open Access | Times Cited: 17
Blood Lipid Metabolic Profiles and Causal Links to Site-Specific Cancer Risks: A Mendelian Randomization Study
Kai Chen, Jin Li, Yan‐Feng Ouyang, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 2, pp. 175-186
Closed Access | Times Cited: 7
Functional Roles of Furin in Cardio-Cerebrovascular Diseases
Surasak Wichaiyo, Pimpisid Koonyosying, Noppawan Phumala Morales
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 570-585
Open Access | Times Cited: 7
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja‐Riitta Taskinen, Chris J. Packard
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 179-204
Closed Access | Times Cited: 7
Comparison of patients with familial chylomicronemia syndrome and multifactorial chylomicronemia syndrome
Catherine M. Spagnuolo, Jian Wang, Adam D. McIntyre, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 7
Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia
Simon‐Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Atherosclerosis (2024) Vol. 392, pp. 117489-117489
Closed Access | Times Cited: 6
Effects of curcumin/turmeric supplementation on lipid profile: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials
Mohammad Jafar Dehzad, Hamid Ghalandari, Mohammad Reza Amini, et al.
Complementary Therapies in Medicine (2023) Vol. 75, pp. 102955-102955
Open Access | Times Cited: 16
Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia
Shyann Hang, Robert A. Hegele, Amanda J. Berberich
Current Opinion in Lipidology (2023) Vol. 34, Iss. 2, pp. 59-69
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top